Astria Therapeutics's total assets for Q3 2025 were $271.87M, a decrease of -3.57% from the previous quarter. ATXS total liabilities were $38.61M for the fiscal quarter, a 80.33% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.